The estimated Net Worth of Maulik Nanavaty is at least $20.5 millió dollars as of 28 February 2022. Mr. Nanavaty owns over 1,630 units of Boston Scientific stock worth over $14,748,557 and over the last 13 years he sold BSX stock worth over $5,720,175. In addition, he makes $0 as Senior Vice President and President - Neuromodulation at Boston Scientific.
Maulik has made over 73 trades of the Boston Scientific stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 1,630 units of BSX stock worth $135,192 on 28 February 2022.
The largest trade he's ever made was selling 78,192 units of Boston Scientific stock on 28 May 2021 worth over $3,330,197. On average, Maulik trades about 7,870 units every 44 days since 2011. As of 28 February 2022 he still owns at least 177,822 units of Boston Scientific stock.
You can see the complete history of Mr. Nanavaty stock trades at the bottom of the page.
Maulik Nanavaty Ph.D. serves as Senior Vice President and President - Neuromodulation of the Company. In this role, he is responsible for the innovation leader in less-invasive microelectronic implantable technologies used to treat chronic neuropathic pain and neurological diseases such as Parkinson's disease and other chronic conditions. Prior to his current role, Mr. Nanavaty was our president of Boston Scientific Japan; he also served as vice president and general manager, Interventional Cardiology, Boston Scientific Japan. Mr. Nanavaty joined Boston Scientific in 2005 as vice president, corporate strategy, Boston Scientific Japan. Prior to joining Boston Scientific, Mr. Nanavaty spent 16 years working in various executive positions at Baxter International, Inc. and Baxter Japan. Mr. Nanavaty earned a Ph.D. in Pharmaceutical Sciences from the University of Illinois and an M.B.A. from the University of Chicago.
Maulik Nanavaty is 58, he's been the Senior Vice President and President - Neuromodulation of Boston Scientific since 2011. There are 7 older and 20 younger executives at Boston Scientific. The oldest executive at Boston Scientific Corp. is Yoshiaki Fujimori, 69, who is the Independent Director.
Maulik's mailing address filed with the SEC is 300 BOSTON SCIENTIFIC WAY, , MARLBOROUGH, MA, 01752-1234.
Over the last 20 years, insiders at Boston Scientific have traded over $938,841,783 worth of Boston Scientific stock and bought 1,398,972 units worth $16,231,539 . The most active insiders traders include Peter M Nicholas, John E Abele és Michael F Mahoney. On average, Boston Scientific executives and independent directors trade stock every 3 days with the average trade being worth of $4,899,929. The most recent stock trade was executed by Michael F Mahoney on 5 September 2024, trading 162,777 units of BSX stock currently worth $13,212,609.
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
Boston Scientific executives and other stock owners filed with the SEC include: